Download PDF
Thromb Haemost 1986; 56(02): 137-143
DOI: 10.1055/s-0038-1661627
Original Article
Schattauer GmbH Stuttgart

Studies on Production of Antithrombin III with Special Reference to Endotoxin-Induced DIC in Dogs

H Tanaka
The Third Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan
,
N Kobayashi
The Third Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan
,
T Maekawa
The Third Department of Internal Medicine, Gunma University School of Medicine, Maebashi, Gunma, Japan
› Author Affiliations
Further Information

Publication History

Received 03 September 1985

Accepted 27 June 1986

Publication Date:
26 July 2018 (online)

  PDF Download  Permissions and Reprints

Summary

The production of antithrombin III (AT III) was studied using Se-75-selenomethionine as a tracer in dogs with disseminated intravascular coagulation (DIC) experimentally induced by endotoxin infusion. Using canine AT III purified by heparin-Sepharose affinity chromatography, antiserum against canine AT III was raised in rabbit. To study the production of plasma AT III, Se-75-selenomethionine was injected into the dog and thereafter the radioactivity incorporated into plasma AT III immunoprecipitated by anti-AT III rabbit serum was serially measured. In normal control dogs, peak radioactivity incorporated into AT III fraction was 970 ± 55 (mean ± SE) cpm/mg of AT III. It was 1196 ± 51.5 cpm/mg, 2748 ± 826 cpm/mg and 1057 ± 74 cpm/mg when Se-75-selenomethionine was injected 6 h, 24 h and 48 h after a single infusion with one mg of endotoxin/kg body weight of dogs, and was 1.2 times, 2.8 times and 1.1 times more than normal control dogs, respectively. Plasma AT III levels decreased to a minimum of 26.7 ± 4.9 mg/dl within 6 h after endotoxin infusion and returned to normal levels by 2 to 3 days after the infusion. Since the catabolic rate of AT III was evidently accelerated, judging from the more rapid decay of the AT III radioactivity, it is suggested that the production of AT III is markedly increased in dogs with DIC induced by endotoxin infusion even during a period of low plasma level.

Key words

Antithrombin III (AT III) - Synthesis of AT III - Se-75-selenomethionine - Endotoxin - DIC
 

  • References

  • 1 Thomas L, Good RA. Studies on the generalized Shwartzman reaction. I. General observations concerning the phenomenon. J Exp Med 1952; 96: 605-624
    PubMedGoogle Scholar
  • 2 Müller-Berghaus G. Pathophysiology of generalized intravascular coagulation. Sem Thromb Hemostas 1977; 3: 209-246
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Tanaka H, Kobayashi N, Maekawa T. Effect of thrombin and endotoxin on the in vivo metabolism of antithrombin III (AT III) in dogs. Thromb Res 1985; 40: 291-306
    CrossrefPubMedGoogle Scholar
  • 4 Bick RL, Duckes ML, Wilson WL, Fekete LF. Antithrombin III (AT III) as a diagnostic aid in disseminated intravascular coagulation. Thromb Res 1977; 10: 721-729
    CrossrefPubMedGoogle Scholar
  • 5 Bick RL, Bick MD, Fekete LF. Antithrombin III pattern in disseminated intravascular coagulation. Am J Clin Pathol 1980; 73: 577-583
    CrossrefPubMedGoogle Scholar
  • 6 Schipper HG, Roos J, Meulen v. d. F, Ten Cate JW. Antithrombin III deficiency in surgical intensive care patients. Thromb Res 1981; 21: 73-80
    CrossrefPubMedGoogle Scholar
  • 7 Bick RL. Clinical relevance of antithrombin III. Sem Thromb Hemostas 1982; 8: 276-287
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Lämmle B, Tran TH, Ritz R, Duckert F. Plasma prekallikrein, factor XII, antithrombin III, C1-inhibitor and α2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC). Am J Clin Pathol 1984; 82: 396-404
    CrossrefPubMedGoogle Scholar
  • 9 Abildgaard U. Antithrombin and related inhibitors of coagulation. In: Recent Advances in Blood Coagulation Poller L. (ed). Vol 3 Churchill Livingstone; Edinburgh - London - Melbourne - New York: 1981: 151-173
  • 10 Laursen B, Mortensen JZ, Frost L, Hansen KB. Disseminated intravascular coagulation in hepatic failure treated with antithrombin III. Thromb Res 1981; 22: 701-704
    CrossrefPubMedGoogle Scholar
  • 11 Laursen B, Farber V, Brock A, Gormsen J, Sørensen H. Disseminated intravascular coagulation, antithrombin III, and complement in meningococcal infections. Acta Med Scand 1981; 209: 221-227
    PubMedGoogle Scholar
  • 12 Jespersen J, Rasmussen NR, Toftgaard C. Observations during the treatment with antithrombin-III concentrate of a case of tampon-related toxic shock syndrome and disseminated intravascular coagulation. Discrepancies between functional and immunologic determinations of antithrombin. Thromb Res 1982; 26: 457-462
    PubMedGoogle Scholar
  • 13 Jespersen J. Liver disease in pregnancy with DIC and low levels of AT III. Scand J Haematol 1983; 30: 492-494
    PubMedGoogle Scholar
  • 14 Liebman HA, McGehee WG, Patch MJ, Feinstein DI. Severe depression of antithrombin III associated with disseminated intravascular coagulation in women with fatty liver of pregnancy. Ann Intern Med 1983; 98: 330-333
    CrossrefPubMedGoogle Scholar
  • 15 Davis BJ. Disc electrophoresis-II. Method and application to human serum proteins. Ann NY Acad Sci 1964; 121: 404-427
    PubMedGoogle Scholar
  • 16 Damus PS, Wallace GA. Purification of canine antithrombin III-heparin cofactor using affinity chromatography. Biochem Biophys Res Commun 1974; 61: 1147-1153
    CrossrefPubMedGoogle Scholar
  • 17 Andrews P. The gel-filtration behaviour of proteins related to their molecular weights over a wide range. Biochem J 1965; 96: 595-605
    CrossrefPubMedGoogle Scholar
  • 18 Rosenberg RD, Damus PS. The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 1973; 248: 6490-6505
    PubMedGoogle Scholar
  • 19 Mancini G, Carbonara AO, Hermans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Internat J Immunochem 1965; 2: 235-254
    PubMedGoogle Scholar
  • 20 McFarlane AS. Efficient trace-labelling of proteins with iodine. Nature 1958; 182: 53
    PubMedGoogle Scholar
  • 21 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
    CrossrefPubMedGoogle Scholar
  • 22 Léon M, Aiach M, Coezy E, Guennec J-Y, Fiessinger J-N. Antithrombin III synthesis in rat liver parenchymal cells. Thromb Res 1983; 30: 369-375
    CrossrefPubMedGoogle Scholar
  • 23 Watada M, Nakagawa M, Kitani T, Okajima Y, Maeda Y, Urano S, Ijichi H. Identification of the AT III synthesizing hepatocytes by immunofluorescent technique. Thromb Haemostas 1981; 46: 284 (Abstr)
    PubMedGoogle Scholar
  • 24 Fair DS, Bahnak BR. Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. Blood 1984; 64: 194-204
    PubMedGoogle Scholar
  • 25 Lee AKY, Chan V, Chan TK. The identification and localization of antithrombin III in human tissues. Thromb Res 1979; 14: 209-217
    CrossrefPubMedGoogle Scholar
  • 26 Chan V, Chan TK. Antithrombin III in fresh and cultured human endothelial cells: A natural anticoagulant from the vascular endothelium. Thromb Res 1979; 15: 209-213
    CrossrefPubMedGoogle Scholar
  • 27 Rivers R PA, Hathaway WE, Weston WL. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol 1975; 30: 311-316
    CrossrefPubMedGoogle Scholar
  • 28 Prydz H, Allison AC. Tissue thromboplastin activity of isolated human monocytes. Thromb Haemostas 1978; 39: 582-591
    PubMedGoogle Scholar
  • 29 Rothberger H, Dove FB, Lee T-K, McGee MP, Kardon B. Procoagulant activity of lymphocyte-macrophage populations in rabbits: selective increases in marrow, blood, and spleen cells during Shwartzman reactions. Blood 1983; 61: 712-717
    PubMedGoogle Scholar
  • 30 Lyberg T, Gaidai KS, Evensen SA, Prydz H. Cellular cooperation in endothelial cell thromboplastin synthesis. Br J Haematol 1983; 53: 85-95
    CrossrefPubMedGoogle Scholar
  • 31 Stern D, Nawroth P, Handley D, Kisiel W. An endothelial cell-dependent pathway of coagulation. Proc Natl Acad Sci USA 1985; 82: 2523-2527
    CrossrefPubMedGoogle Scholar